USFDA likely to clear Pfizer boosters for 12-15-yr-olds on Mon

NEW YORK: The US FDA plans on Monday to authorize booster doses of Pfizer-BioNTech's vaccine for 12- to 15-year-olds, the NYT reported on Thursday, citing people familiar with FDA deliberations.
US regulators also plan to cut the time gap for both adolescents and adults to get a booster shot of Pfizer's vaccine to five months after a second dose, from the current 6 months, the report said .